| Jacob Health Care Center, Llc | |
| 4075 54th St., San Diego, California 92105 | |
| (619) 582-5168 | |
| Name | Jacob Health Care Center, Llc |
|---|---|
| Location | 4075 54th St., San Diego, California |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 128 |
| Occupancy Rate | 96.33% |
| Medicare ID (CCN) | 055508 |
| Legal Business Name | Jacob Health Care Center Lp |
| Ownership Type | For Profit - Partnership |
| NPI Number | 1326738345 |
| Organization Name | UTAH LAKE HOLDINGS LLC |
| Address | 4075 54th St, San Diego, CA 92105 |
| Phone Number | 858-798-5700 |
News Archive
Researchers from the Centenary Institute have developed a new approach to fighting melanomas that fail to respond – or are resistant – to standard treatments. The deadliest form of skin cancer, melanoma is responsible for more than 1,700 deaths each year in Australia.
The coronavirus disease (COVID-19) outbreak has taken a toll on the lives of many people, especially in mainland China. However, over the past week, the virus has spread to more than 40 countries, infecting over 83,000 people with more than 2,800 deaths. Now, the UK's case toll increased to 16 as Northern Ireland reported its first coronavirus case.
BioNanomatrix, Inc. has announced receipt of a grant from the National Human Genome Research Institute of the U.S. National Institutes of Health (NIH). Under the direction of BioNanomatrix principal investigator Dr. Ming Xiao, the two-year $399,020 project will develop a nanoscale platform for single-molecule haplotyping imaging and analysis of long strands of DNA at ultra-high resolution in a massively parallel format.
Researchers in Argentina report that women with multiple sclerosis (MS) who undergo assisted reproduction technology (ART) infertility treatment are at risk for increased disease activity.
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) Small Business Innovation Research grant (SBIR) for a program on "Clinical Vector for TCR Immunotherapy Targeted to Melanoma". In this program, Lentigen will collaborate with Dr. Michael Nishimura, Professor of Surgery, at the Medical University of South Carolina (MUSC).
› Verified 4 days ago
| NPI Number | 1881684900 |
| Organization Name | JACOB HEALTH CARE CENTER LP |
| Address | 4075 54th St, San Diego, CA 92105 |
| Phone Number | 323-556-0040 |
News Archive
Researchers from the Centenary Institute have developed a new approach to fighting melanomas that fail to respond – or are resistant – to standard treatments. The deadliest form of skin cancer, melanoma is responsible for more than 1,700 deaths each year in Australia.
The coronavirus disease (COVID-19) outbreak has taken a toll on the lives of many people, especially in mainland China. However, over the past week, the virus has spread to more than 40 countries, infecting over 83,000 people with more than 2,800 deaths. Now, the UK's case toll increased to 16 as Northern Ireland reported its first coronavirus case.
BioNanomatrix, Inc. has announced receipt of a grant from the National Human Genome Research Institute of the U.S. National Institutes of Health (NIH). Under the direction of BioNanomatrix principal investigator Dr. Ming Xiao, the two-year $399,020 project will develop a nanoscale platform for single-molecule haplotyping imaging and analysis of long strands of DNA at ultra-high resolution in a massively parallel format.
Researchers in Argentina report that women with multiple sclerosis (MS) who undergo assisted reproduction technology (ART) infertility treatment are at risk for increased disease activity.
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) Small Business Innovation Research grant (SBIR) for a program on "Clinical Vector for TCR Immunotherapy Targeted to Melanoma". In this program, Lentigen will collaborate with Dr. Michael Nishimura, Professor of Surgery, at the Medical University of South Carolina (MUSC).
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Researchers from the Centenary Institute have developed a new approach to fighting melanomas that fail to respond – or are resistant – to standard treatments. The deadliest form of skin cancer, melanoma is responsible for more than 1,700 deaths each year in Australia.
The coronavirus disease (COVID-19) outbreak has taken a toll on the lives of many people, especially in mainland China. However, over the past week, the virus has spread to more than 40 countries, infecting over 83,000 people with more than 2,800 deaths. Now, the UK's case toll increased to 16 as Northern Ireland reported its first coronavirus case.
BioNanomatrix, Inc. has announced receipt of a grant from the National Human Genome Research Institute of the U.S. National Institutes of Health (NIH). Under the direction of BioNanomatrix principal investigator Dr. Ming Xiao, the two-year $399,020 project will develop a nanoscale platform for single-molecule haplotyping imaging and analysis of long strands of DNA at ultra-high resolution in a massively parallel format.
Researchers in Argentina report that women with multiple sclerosis (MS) who undergo assisted reproduction technology (ART) infertility treatment are at risk for increased disease activity.
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) Small Business Innovation Research grant (SBIR) for a program on "Clinical Vector for TCR Immunotherapy Targeted to Melanoma". In this program, Lentigen will collaborate with Dr. Michael Nishimura, Professor of Surgery, at the Medical University of South Carolina (MUSC).
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 5.65 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 3.66 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 35.53 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.25 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.99 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 5.44 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.29 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 13.05 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 20.88 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 5.51 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.07 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 89.95 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 100 | 82.93 |
News Archive
Researchers from the Centenary Institute have developed a new approach to fighting melanomas that fail to respond – or are resistant – to standard treatments. The deadliest form of skin cancer, melanoma is responsible for more than 1,700 deaths each year in Australia.
The coronavirus disease (COVID-19) outbreak has taken a toll on the lives of many people, especially in mainland China. However, over the past week, the virus has spread to more than 40 countries, infecting over 83,000 people with more than 2,800 deaths. Now, the UK's case toll increased to 16 as Northern Ireland reported its first coronavirus case.
BioNanomatrix, Inc. has announced receipt of a grant from the National Human Genome Research Institute of the U.S. National Institutes of Health (NIH). Under the direction of BioNanomatrix principal investigator Dr. Ming Xiao, the two-year $399,020 project will develop a nanoscale platform for single-molecule haplotyping imaging and analysis of long strands of DNA at ultra-high resolution in a massively parallel format.
Researchers in Argentina report that women with multiple sclerosis (MS) who undergo assisted reproduction technology (ART) infertility treatment are at risk for increased disease activity.
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) Small Business Innovation Research grant (SBIR) for a program on "Clinical Vector for TCR Immunotherapy Targeted to Melanoma". In this program, Lentigen will collaborate with Dr. Michael Nishimura, Professor of Surgery, at the Medical University of South Carolina (MUSC).
› Verified 4 days ago
Kearny Mesa Convalescent And Nursing Home Location: 7675 Family Circle Drive, San Diego, California 92111 Phone: (858) 278-8121 | |
The Pavilion At Ocean Point Location: 3202 Duke Street, San Diego, California 92110 Phone: (619) 224-4141 | |
University Care Center Location: 5602 University Ave, San Diego, California 92105 Phone: (619) 583-1993 | |
Arroyo Vista Nursing Center Location: 3022 45th Street, San Diego, California 92105 Phone: (619) 283-5855 | |
Jacob Health Care Center, Llc Location: 4075 54th St., San Diego, California 92105 Phone: (619) 582-5168 | |
Abby Gardens Healthcare Center Location: 8060 Frost Street, San Diego, California 92123 Phone: (858) 278-4750 |